Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Cooper

Showing results (241-250 of 399) with videos related to

Pageof 40
Sort By:
Diabetes Care|January 31, 2006
Serum lipids and the progression of nephropathy in type 1 diabetesMerlin C Thomas, Milla Rosengård-Bärlund, Vashti Mills, et al.
Journal of the American Society of Nephrology : JASN|June 29, 2002
Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injuryZemin Cao, Fabrice Bonnet, Riccardo Candido, et al.
Diabetes|March 29, 2014
Bilirubin and progression of nephropathy in type 2 diabetes: a post hoc analysis of RENAAL with independent replication in IDNTIneke J Riphagen, Petronella E Deetman, Stephan J L Bakker, et al.
American Journal of Physiology. Renal Physiology|October 17, 2008
Heat shock protein expression in diabetic nephropathyFederica Barutta, Silvia Pinach, Sara Giunti, et al.
Diabetes & Vascular Disease Research|July 31, 2015
Dipeptidyl peptidase-4 inhibition with linagliptin and effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: Rationale and design of the MARLINA-T2D™ trialPer-Henrik Groop, Mark E Cooper, Vlado Perkovic, et al.
Diabetes|April 18, 2014
Derivative of bardoxolone methyl, dh404, in an inverse dose-dependent manner lessens diabetes-associated atherosclerosis and improves diabetic kidney diseaseSih Min Tan, Arpeeta Sharma, Nada Stefanovic, et al.
Circulation|July 10, 2002
Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient miceRiccardo Candido, Karin A Jandeleit-Dahm, Zemin Cao, et al.
Journal of the American Society of Nephrology : JASN|November 23, 2013
Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expressionChet E Holterman, Jean-François Thibodeau, Chelsea Towaij, et al.
Circulation|August 11, 2004
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathyDick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, et al.
Kidney International|May 20, 2004
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAALDick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, et al.
Pageof 40

Showing results (241-250 of 399) with videos related to

Sort By:
Pageof 40
Diabetes Care|January 31, 2006
Serum lipids and the progression of nephropathy in type 1 diabetesMerlin C Thomas, Milla Rosengård-Bärlund, Vashti Mills, et al.
Journal of the American Society of Nephrology : JASN|June 29, 2002
Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injuryZemin Cao, Fabrice Bonnet, Riccardo Candido, et al.
Diabetes|March 29, 2014
Bilirubin and progression of nephropathy in type 2 diabetes: a post hoc analysis of RENAAL with independent replication in IDNTIneke J Riphagen, Petronella E Deetman, Stephan J L Bakker, et al.
American Journal of Physiology. Renal Physiology|October 17, 2008
Heat shock protein expression in diabetic nephropathyFederica Barutta, Silvia Pinach, Sara Giunti, et al.
Diabetes & Vascular Disease Research|July 31, 2015
Dipeptidyl peptidase-4 inhibition with linagliptin and effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: Rationale and design of the MARLINA-T2D™ trialPer-Henrik Groop, Mark E Cooper, Vlado Perkovic, et al.
Diabetes|April 18, 2014
Derivative of bardoxolone methyl, dh404, in an inverse dose-dependent manner lessens diabetes-associated atherosclerosis and improves diabetic kidney diseaseSih Min Tan, Arpeeta Sharma, Nada Stefanovic, et al.
Circulation|July 10, 2002
Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient miceRiccardo Candido, Karin A Jandeleit-Dahm, Zemin Cao, et al.
Journal of the American Society of Nephrology : JASN|November 23, 2013
Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expressionChet E Holterman, Jean-François Thibodeau, Chelsea Towaij, et al.
Circulation|August 11, 2004
Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathyDick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, et al.
Kidney International|May 20, 2004
Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAALDick de Zeeuw, Giuseppe Remuzzi, Hans-Henrik Parving, et al.
Pageof 40